» Articles » PMID: 35126394

Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions

Overview
Journal Front Immunol
Date 2022 Feb 7
PMID 35126394
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic foot ulcer (DFU) frequently leads to non-traumatic amputation and finally even death. However, the mechanism of DFU is not fully understood. Interleukin 25 (IL-25), an alarmin cytokine that responds to tissue injury, has been reported to participate in tissue regeneration and maintaining glucose homeostasis. However, the role of IL-25 in diabetic wound healing remains unknown. Here, we showed that interleukin 17 receptor B (IL-17RB), the functional receptor of IL-25, was significantly inhibited in the wound skin of both diabetic patients with DFU and streptozotocin (STZ)-induced diabetic mice. Topical administration of recombinant IL-25 protein improved angiogenesis and collagen deposition in the wound bed and thus ameliorated delayed diabetic wound healing. IL-25 increased endothelial-specific CD31 expression in diabetic wounds and exogenous IL-25 protected endothelial cells from high glucose-impaired cell migration and tube formation . We further revealed that IL-25-mediated-IL-17RB signaling rescued the downregulation of Wnt/β-catenin pathway both in diabetic mice and in HUVECs and induced the phosphorylation of AKT and ERK 1/2 in HUVECs under high glucose conditions. This study defines a positive regulatory role of IL-25-mediated-IL-17RB signaling in diabetic wound healing and suggests that induction of IL-25-mediated-IL-17RB signaling may be a novel therapeutic strategy for treating poor healing diabetic wounds.

Citing Articles

Wound management, healing, and early prosthetic rehabilitation: Part 2 - A scoping review of physical biomarkers.

Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43716.

PMID: 39990247 PMC: 11844764. DOI: 10.33137/cpoj.v7i2.43716.


Wound management, healing, and early prosthetic rehabilitation: Part 1 - A scoping review of healing and non-healing definitions.

Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43715.

PMID: 39990241 PMC: 11844765. DOI: 10.33137/cpoj.v7i2.43715.


Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers.

Yu X, Wu Z, Zhang N Mol Med. 2024; 30(1):215.

PMID: 39543487 PMC: 11562697. DOI: 10.1186/s10020-024-00955-z.


Trained immunity of intestinal tuft cells during infancy enhances host defense against enteroviral infections in mice.

Chen D, Wu J, Zhang F, Lyu R, You Q, Qian Y EMBO Mol Med. 2024; 16(10):2516-2538.

PMID: 39261649 PMC: 11479266. DOI: 10.1038/s44321-024-00128-9.


Preparation of Luvangetin Nanoemulsions: Antimicrobial Mechanism and Role in Infected Wound Healing.

Chong Y, Yu D, Han R, Li Y, Gu Y, Lu Z Int J Nanomedicine. 2024; 19:5493-5509.

PMID: 38882542 PMC: 11178095. DOI: 10.2147/IJN.S457322.


References
1.
Hams E, Locksley R, McKenzie A, Fallon P . Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J Immunol. 2013; 191(11):5349-53. PMC: 3847854. DOI: 10.4049/jimmunol.1301176. View

2.
Gregory L, Jones C, Walker S, Sawant D, Gowers K, Campbell G . IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax. 2012; 68(1):82-90. PMC: 3534261. DOI: 10.1136/thoraxjnl-2012-202003. View

3.
Gurtner G, Werner S, Barrandon Y, Longaker M . Wound repair and regeneration. Nature. 2008; 453(7193):314-21. DOI: 10.1038/nature07039. View

4.
Galkowska H, Wojewodzka U, Olszewski W . Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 2006; 14(5):558-65. DOI: 10.1111/j.1743-6109.2006.00155.x. View

5.
Chen X, Duong M, Psaltis P, Bursill C, Nicholls S . High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes. Cardiovasc Diabetol. 2017; 16(1):121. PMC: 5622442. DOI: 10.1186/s12933-017-0605-8. View